Introduction
Date : 21 August 2026
CLAIRITY CONNECT – Chandigarh 2026 brought together pharmaceutical professionals, scientists, and quality experts from Chandigarh and Baddi for an insightful evening of knowledge sharing, technical discussions, live demonstrations, and networking.
The event created a valuable platform to engage in meaningful conversations around evolving regulatory expectations, strengthening quality standards, and the role of automation and AI in improving productivity, accuracy, and reducing manual transcription errors across pharmaceutical R&D, Quality Control, Microbiology, and packaging processes.
Exploring the CLAIRITY™ Platform
The session began with an introduction to the CLAIRITY™ platform and its AI/ML-powered capabilities, covering solutions for Particle Analysis, Thermal Analysis, Seam Analysis, Microbiology, Proofreading, and Cell Analysis.
Participants were introduced to the diverse applications of the CLAIRITY™ product suite and how intelligent automation can support pharmaceutical laboratories in achieving more reliable, efficient, and data-driven workflows.
Technical Discussions and Real-World Applications
A major highlight of CLAIRITY CONNECT was the technical session featuring real-world case studies and applications in pharmaceutical R&D, QC, and Microbiology.
The discussions explored the critical role of microscopic particle characterization in formulation development and stability studies, demonstrating how AI-based morphology analysis can help enhance dissolution predictability and identify critical material attributes at an early stage.
Several important applications were discussed, including:
- Particle morphology analysis for formulation and stability studies
- Reverse engineering of multi-component formulations
- Root cause analysis of bioequivalence failures through morphology-led investigations
- Glass delamination studies and visible and sub-visible particulate matter analysis
- PLM-based asbestos identification in talc
- Automated microbial colony counting
- AI-assisted proofreading and packaging inspection
- Cell viability and seam analysis for biologics and soft-gel dosage forms
The event also highlighted the role of microscopic particle characterization in Analytical R&D and pharmaceutical product development, reinforcing the importance of understanding particle size, shape, and morphology early in the development process.
Quality Beyond Market Boundaries
One important question emerged from the discussions:
Should quality standards and parameters be designed based on domestic supply, export requirements, or ultimately, human lives?
The answer is clear—patient safety must always remain the ultimate consideration.
A key focus of the discussions was the latest USP <901> requirement, effective from 1 June 2026, concerning talc used in pharmaceutical applications and the need to ensure it is free from asbestos.
The discussions emphasized that such critical quality considerations should not be limited to products intended for export markets. Patient safety should not be differentiated by the destination of the product. Wherever human health is concerned, the commitment to quality must remain consistent.
Live Demonstrations and Industry Interaction
The evening concluded with dinner, networking, open interaction, and live demonstrations of CLAIRITY™ solutions, including:
- CLAIRITY™ Auto – Automated Particle Size & Count Analysis
- CLAIRITY™ Particle – Morphology & Shape Analysis
- CLAIRITY™ Microbe – Automated Colony Counter
- CLAIRITY™ ProofCheck – Smart Proofreading System
The live demonstrations gave participants an opportunity to experience the practical capabilities of the technology and engage directly with the ImageProVision team.
Moving Towards a Technology-Enabled Quality Culture
It was encouraging to interact with scientists and quality professionals who are actively addressing critical industry challenges and driving the pharmaceutical sector towards a more robust, technology-enabled quality culture.
We sincerely thank our North India Channel Partner, Elegance Life Sciences Pvt. Ltd., and their entire team for their support in making these meaningful interactions possible.
A heartfelt thanks also goes to all the participating pharmaceutical professionals and the ImageProVision team for making CLAIRITY CONNECT – Chandigarh 2026 a valuable platform for collaboration, learning, and meaningful dialogue.
Through CLAIRITY CONNECT, we continue to bring together technology, scientific expertise, and industry collaboration—with one common goal: building stronger quality systems and supporting safer pharmaceutical products.
